12. Alternate Synthesis of Acyclovir and their uses thereof    

11. A COST EFFECTIVE PROCESS FOR PREPARATION OF NINTEDANIB

, 0240NF2024; IN202513002027     

10. Purine Based Phthalazinones as dual PARP and mTOR Inhibitors and use thereof; Indranil Chatterjee, Saumya Ranjan Satrusal, Biswajit Mandal, Arpita Banerjee, Sanjeev Meena, Arpon Biswas, Rabi Sankar Bhatta, Gautam Panda, Dipak Datta; 0083NF2024/IN; CDRI; 15-May-2024, IN 202411038350   

9. 2-Pyridone based quinazoline compounds as dual EZH2 and EGFR Inhibitors; Arpita Banerjee, Saumya Ranjan Satrusal, Indranil Chatterjee, Priyanka Rai, Muqtada Ali Khan, Arpon Biswas, Rabi Sankar Bhatta, Jiaur Rahaman Gayen, Aamir Nazir, Gautam Panda, Dipak Datta; 0082NF2024/IN; CDRI; 09-May-2024; IN 202411036881   

8. Amino Acid based Poly(ADP-ribose)polymerase (PARP) Inhibitors and their application against BRCA mutated cancers and uses thereof, 0229NF2023; IN 202411019816  

7. Process for preparation of Phthalazinone (Olaparib) derivatives and uses thereof; Deblina Roy, Indranil Chatterjee and Gautam Panda, IN 202211013919, Date of filing 14/03/2022; PUBLICATION DATE (U/S 11A) 12/01/2024; Open for Licensing   

6.   New Synthesis of Nintedanib, its key starting materials and key synthetic intermediates and their uses thereof; Gautam Panda, Saroj Maji, IN 202211006560 Date of filing 07/02/2022; 

PUBLICATION DATE (U/S 11A) 11/08/2023, Open for Licensing  

5. Process for preparation of  diphenylmethylpiperazine derivatives and their uses thereof; Gautam Panda, Deblina Roy, Arpita Banerjee, patent submitted (0209NF2020); Application number IN 202111003021 dated 21.01.2021, Detailed Research Work Shared with Reliance Rasayan Private Limited (RRPL), Ahmedabad, DCGI has given permission for Phase II trial for ALI including Covid-19 patients

4. Process for preparation of phenylethanolamine compounds and use thereof; Gautam Panda, Deblina Roy, patent submitted (0210NF2020); Application number IN 202111015502 dated 31.03.2021; Detailed Research Work Shared with Reliance Rasayan Private Limited (RRPL), Ahmedabad; DCGI has given permission for Phase II trial for ALI including Covid-19 patients

1. Diaryloxy Methano Phenanthrenes: A New Class of Antituberculosis Agents; Gautam Panda, Shagufta, Jitendra Kumar Mishra, Vinita Chaturvedi, Anil K. Srivastava, Manju, Ranjana Srivastava and Brahm S. Srivastava2003, Patent No. 535/03. 1178/DEL/2004 Filing date 24/06/04